Arthrex
Device Arthroplasty - Implants - Revers Total Shoulder - Revers
PDI 00888867234192
General payments
$26,269,258
Research payments
$5,950
Through program year 2024, $26,269,258 in general payments and $5,950 in research payments were reported against Arthrex (Revers Total Shoulder - Revers).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $6,762 | 78 |
| 2023 | General | $9,122,578 | 192 |
| 2023 | Research | $5,950 | 1 |
| 2022 | General | $9,742,037 | 28 |
| 2021 | General | $7,397,881 | 27 |
Breakdown
The top 5 of 66 recipients; each share is of general payments naming this product in 2024.
The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 29 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
325 general · 1 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.